{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:24:35Z","timestamp":1789511075161,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS098772"],"award-info":[{"award-number":["1R01NS098772"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01DA042852"],"award-info":[{"award-number":["1R01DA042852"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["NF1000099"],"award-info":[{"award-number":["NF1000099"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","award":["2015-04-009A"],"award-info":[{"award-number":["2015-04-009A"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81571231"],"award-info":[{"award-number":["81571231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","award":["2015-01-011"],"award-info":[{"award-number":["2015-01-011"]}],"id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.neuroscience.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T13:56:30Z","timestamp":1523541390000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["CRMP2\u2013Neurofibromin Interface Drives NF1-related Pain"],"prefix":"10.1016","volume":"381","author":[{"given":"Aubin","family":"Moutal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wennan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2018.04.002_b0005","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10897-016-9939-8","article-title":"Quality of life in adults with neurofibromatosis 1 in Brazil","volume":"25","author":"Bicudo","year":"2016","journal-title":"J Genet Couns"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0010","doi-asserted-by":"crossref","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","article-title":"An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels","volume":"284","author":"Brittain","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0015","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.2345","article-title":"Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2)(+) channel complex","volume":"17","author":"Brittain","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0020","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.febslet.2012.09.022","article-title":"Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2","volume":"586","author":"Brittain","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2018.04.002_b9000","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1042\/NS20170220","article-title":"CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain","volume":"2","author":"Chew","year":"2018","journal-title":"Neuronal Signaling"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0025","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1242\/jcs.053280","article-title":"Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons","volume":"122","author":"Chi","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10897-015-9829-5","article-title":"The impact of neurofibromatosis type 1 on the health and wellbeing of australian adults","volume":"24","author":"Crawford","year":"2015","journal-title":"J Genet Couns"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/brain\/122.3.473","article-title":"Neurological complications of neurofibromatosis type 1 in adulthood","volume":"122","author":"Creange","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn3404","article-title":"The Na(V)1.7 sodium channel: from molecule to man","volume":"14","author":"Dib-Hajj","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0050","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/brain\/awh234","article-title":"Neurofibromatosis 1-associated neuropathies: a reappraisal","volume":"127","author":"Drouet","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuroscience.2014.04.021","article-title":"N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+\/\u2212 mice","volume":"270","author":"Duan","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0060","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1074\/jbc.M113.474924","article-title":"CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking","volume":"288","author":"Dustrude","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0065","doi-asserted-by":"crossref","first-page":"E8443","DOI":"10.1073\/pnas.1610531113","article-title":"Hierarchical CRMP2 posttranslational modifications control NaV1.7 function","volume":"113","author":"Dustrude","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/19336950.2017.1299838","article-title":"A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function","volume":"11","author":"Dustrude","year":"2017","journal-title":"Channels"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/jnc.13396","article-title":"A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1","volume":"135","author":"Esposito","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0085","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1523\/JNEUROSCI.21-23-09142.2001","article-title":"Targeted mutations in the syntaxin H3 domain specifically disrupt SNARE complex function in synaptic transmission","volume":"21","author":"Fergestad","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12955-017-0607-y","article-title":"Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the impact of NF1 on quality of life (INF1-QOL) questionnaire","volume":"15","author":"Ferner","year":"2017","journal-title":"Health Quality Life Outcomes"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/j.pain.0000000000000147","article-title":"A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors","volume":"156","author":"Francois-Moutal","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ncb825","article-title":"CRMP-2 binds to tubulin heterodimers to promote microtubule assembly","volume":"4","author":"Fukata","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/376509a0","article-title":"Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33","volume":"376","author":"Goshima","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0115","doi-asserted-by":"crossref","first-page":"17917","DOI":"10.1074\/jbc.C000179200","article-title":"Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules","volume":"275","author":"Gu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0125","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2005.09.030","article-title":"Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene","volume":"137","author":"Hingtgen","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbr.2011.03.038","article-title":"Sex differences and phase of light cycle modify chronic stress effects on anxiety and depressive-like behavior","volume":"222","author":"Huynh","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jnc.12070","article-title":"Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide","volume":"124","author":"Ju","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0169-328X(97)00332-X","article-title":"Isolation and characterization of a bovine neural specific protein (CRMP-2) cDNA homologous to unc-33, a C. elegans gene implicated in axonal outgrowth and guidance","volume":"54","author":"Kamata","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0145","article-title":"Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene targeted mice","author":"Kanellopoulos","year":"2017","journal-title":"BioRxiv"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0150","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1471-4159.2005.03063.x","article-title":"Tubulin and CRMP-2 complex is transported via Kinesin-1","volume":"93","author":"Kimura","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000187594","article-title":"Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patients","volume":"218","author":"Kodra","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0160","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbrc.2008.02.095","article-title":"Neurofibromin interacts with CRMP-2 and CRMP-4 in rat brain","volume":"369","author":"Lin","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/355827a0","article-title":"P-type calcium channels blocked by the spider toxin omega-Aga-IVA","volume":"355","author":"Mintz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0170","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/j.pain.0000000000000555","article-title":"(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology","volume":"157","author":"Moutal","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuroscience.2018.04.002_b0175","doi-asserted-by":"crossref","first-page":"pii: e565","DOI":"10.1097\/PR9.0000000000000565","article-title":"Efficacy of (S)-lacosamide in preclinical models of cephalic pain","volume":"1","author":"Moutal","year":"2016","journal-title":"Pain Rep"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0180","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s12035-015-9141-2","article-title":"(S)-Lacosamide binding to collapsin response mediator protein 2 (CRMP2) regulates CaV2.2 activity by subverting its phosphorylation by Cdk5","volume":"53","author":"Moutal","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neuroscience.2018.04.002_b0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/19336950.2017.1370524","article-title":"CRMP2 is necessary for neurofibromatosis type 1 related pain","volume":"12","author":"Moutal","year":"2017","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0190","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1007\/s12035-016-9907-1","article-title":"Sensitization of ion channels contributes to central and peripheral dysfunction in neurofibromatosis Type 1","volume":"54","author":"Moutal","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0195","article-title":"Blocking CRMP2 SUMOylation reverses neuropathic pain","author":"Moutal","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0200","article-title":"Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides","author":"Moutal","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0205","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000001026","article-title":"Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors","author":"Moutal","year":"2017","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.neuroscience.2018.04.002_b0210","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/j.pain.0000000000001002","article-title":"CRISPR\/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1 (NF1)-related pain that is reversed by (S)-lacosamide","volume":"158","author":"Moutal","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0215","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0220","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1038\/s41598-017-11031-4","article-title":"Structural basis for CRMP2-induced axonal microtubule formation","volume":"7","author":"Niwa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0225","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1074\/jbc.M708206200","article-title":"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2","volume":"283","author":"Patrakitkomjorn","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1744-8069-8-54","article-title":"CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy","volume":"8","author":"Piekarz","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0235","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ajmg.a.38079","article-title":"First report of factors associated with satisfaction in patients with neurofibromatosis","volume":"173","author":"Riklin","year":"2017","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0245","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1523\/JNEUROSCI.12-06-02104.1992","article-title":"Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons","volume":"12","author":"Roy","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0250","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.97.7.3666","article-title":"Direct interaction between synaptotagmin and the intracellular loop I-II of neuronal voltage-sensitive sodium channels","volume":"97","author":"Sampo","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0255","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1113\/jphysiol.1992.sp018944","article-title":"Calcium current variation between acutely isolated adult rat dorsal root ganglion neurons of different size","volume":"445","author":"Scroggs","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0265","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1471-4159.2006.04401.x","article-title":"The structure of human collapsin response mediator protein 2, a regulator of axonal growth","volume":"101","author":"Stenmark","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/md15090269","article-title":"Ciguatoxins evoke potent CGRP release by activation of voltage-gated sodium channel subtypes NaV1.9, NaV1.7 and NaV1.1","volume":"15","author":"Touska","year":"2017","journal-title":"Mar Drugs"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2443.2005.00827.x","article-title":"Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease","volume":"10","author":"Uchida","year":"2005","journal-title":"Genes Cells"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0280","doi-asserted-by":"crossref","first-page":"27393","DOI":"10.1074\/jbc.M109.000240","article-title":"Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32","volume":"284","author":"Uchida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0285","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1046\/j.1471-4159.1997.69062261.x","article-title":"Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase","volume":"69","author":"Wang","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0290","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1152\/jn.00489.2005","article-title":"Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability","volume":"94","author":"Wang","year":"2005","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2478\/v10134-010-0025-8","article-title":"Altered calcium currents and axonal growth in Nf1 haploinsufficient mice","volume":"1","author":"Wang","year":"2010","journal-title":"Transl Neurosci"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0300","article-title":"Augmented sodium currents contribute to enhanced excitability of small diameter capsaicin-sensitive Nf1+\/\u2212 mouse sensory neurons","author":"Wang","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0305","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","article-title":"Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases","volume":"137","author":"Wolkenstein","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0310","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/ajmg.a.37123","article-title":"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life","volume":"167A","author":"Wolters","year":"2015","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.neuroscience.2018.04.002_b0315","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol Behav"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218302537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452218302537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:44:32Z","timestamp":1759679072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452218302537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":63,"alternative-id":["S0306452218302537"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.04.002","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRMP2\u2013Neurofibromin Interface Drives NF1-related Pain","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}